TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Return
21.62%
This Quarter Return
+20.4%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$815M
AUM Growth
+$156M
(+24%)
Cap. Flow
+$89.5M
Cap. Flow
% of AUM
10.98%
Top 10 Holdings %
Top 10 Hldgs %
43.07%
Holding
100
New
33
Increased
19
Reduced
13
Closed
5
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$20M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$14.2M |
| 3 |
Heron Therapeutics
HRTX
|
$13.2M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
$13.2M |
| 5 |
Insmed
INSM
|
$10.8M |
Top Sells
| 1 |
Veru
VERU
|
$40.7M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$30.6M |
| 3 |
Altimmune
ALT
|
$12.8M |
| 4 |
BioAtla
BCAB
|
$10.8M |
| 5 |
Inspirato
ISPO
|
$6M |
Sector Composition
| 1 | Healthcare | 96.03% |
| 2 | Communication Services | 1.61% |
| 3 | Consumer Discretionary | 0.82% |
| 4 | Consumer Staples | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LENZ
51
LENZ Therapeutics
LENZ
$1.14B
| $3.49M | 0.43% |
157,143
| – | – |
|
|
SWTX
52
DELISTED
SpringWorks Therapeutics
SWTX
| $3.42M | 0.42% |
+120,000
| New | +$3.42M |
|
|
ASLN
53
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $3.39M | 0.42% |
141,373
+2,500
| +2% | +$59.9K |
|
54
Esperion Therapeutics
ESPR
$510M
| $3.35M | 0.41% |
+500,000
| New | +$3.35M |
|
|
ATYR
55
aTyr Pharma
ATYR
$536M
| $3.34M | 0.41% |
1,113,453
| – | – |
|
56
CRISPR Therapeutics
CRSP
$4.8B
| $3.27M | 0.4% |
+50,000
| New | +$3.27M |
|
57
Legend Biotech
LEGN
$6.46B
| $3.26M | 0.4% |
80,000
+30,000
| +60% | +$1.22M |
|
58
ANI Pharmaceuticals
ANIP
$2.08B
| $3.21M | 0.39% |
100,000
| – | – |
|
|
EGRX
59
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.14M | 0.39% |
+118,857
| New | +$3.14M |
|
60
Axsome Therapeutics
AXSM
$6.21B
| $3.12M | 0.38% |
+70,000
| New | +$3.12M |
|
61
Clene
CLNN
$59.4M
| $3.08M | 0.38% |
+55,000
| New | +$3.08M |
|
62
Gossamer Bio
GOSS
$571M
| $3M | 0.37% |
+250,000
| New | +$3M |
|
63
Pyxis Oncology
PYXS
$99.8M
| $2.78M | 0.34% |
1,411,569
+32,489
| +2% | +$64K |
|
|
BPMC
64
DELISTED
Blueprint Medicines
BPMC
| $2.64M | 0.32% |
+40,000
| New | +$2.64M |
|
|
CCXI
65
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.58M | 0.32% |
50,000
| – | – |
|
66
Vanda Pharmaceuticals
VNDA
$274M
| $2.54M | 0.31% |
256,696
| – | – |
|
67
ADMA Biologics
ADMA
$4.04B
| $2.41M | 0.3% |
+992,840
| New | +$2.41M |
|
68
Beam Therapeutics
BEAM
$1.88B
| $2.38M | 0.29% |
+50,000
| New | +$2.38M |
|
69
ARS Pharmaceuticals
SPRY
$1.06B
| $2.16M | 0.27% |
+409,463
| New | +$2.16M |
|
|
BLU
70
DELISTED
BELLUS Health Inc.
BLU
| $2.11M | 0.26% |
200,000
-400,000
| -67% | -$4.22M |
|
71
MoonLake Immunotherapeutics
MLTX
$3.79B
| $2.01M | 0.25% |
259,054
-59,989
| -19% | -$465K |
|
72
Aligos Therapeutics
ALGS
$74.7M
| $1.84M | 0.23% |
66,967
+5,059
| +8% | +$139K |
|
|
CTIC
73
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.75M | 0.21% |
+300,000
| New | +$1.75M |
|
74
TScan Therapeutics
TCRX
$107M
| $1.7M | 0.21% |
557,915
-189,885
| -25% | -$579K |
|
75
Aurinia Pharmaceuticals
AUPH
$1.65B
| $1.5M | 0.18% |
+200,000
| New | +$1.5M |
|